Research On The Financing Performance Of Asymchem’s Private Placement Under The New Regulations

When the company’s operation and operation,funds played a pivotal role.For Chinese companies,they usually use re-financing as the preferred funding method.Throughout the development of Chinese companies’ re-financing,it can be divided into three categories: allocation of shares,public issuance and directional issuance.When this re-financing method has not yet been clearly issued,it has not been clearly stipulated,and the re-financing methods of Chinese companies are mainly distribution and public offering of stocks.Later,in 2006,the relevant state departments stipulated the directional additional issuance,allowing some enterprises to conduct financing,and the directional issuance gradually occupied an important position in the securities market.Related regulations for directional issuance have been revised several times,and by2020,the "New Regulations for Re-Financing" have been released,which has changed greatly.The lock-up period has been greatly shortened,the number of issued objects has widened and the discounts of the reserve price have been increased again,which has made the fixed-increasing market’s attractiveness to the capital side and financing party,thereby participating in the more diversified funds and subjects that are involved in orientation,and also increased,and also increased.The success rate of targeted issuance and distribution.Through targeted additional issuance,enterprises can effectively reduce financing costs,obtain rich capital support,expand scale,increase profitability,and increase their own investment value.Under this new regulations,once the problem of increasing performance is clear,it will help listed companies to make more favorable financing decisions in the future,choose more conducive to financing methods of enterprises,thereby increasing the company’s value.This article selects the targeted issuance plan issued by Kailai British Pharmaceutical Group Co.,Ltd.after the revision of the new regulations of 2020 as a typical case,and adopts research methods such as event research,literature research,case research,and factor analysis.After the addition,the impact of the market performance and financial performance of Kailai British Pharmaceutical Group.The thesis sorted out the course of the re-financing policy and the comparison of the new regulations before and after the re-financing regulations.The impact of the new regulations on the new regulations on the directional issuance market is analyzed from the perspective of financing enterprises.The targeted additional issue plan for the pharmaceutical group analyzes the impact of the revenue,cash flow,and corporate capacity scale of the company after the new regulations for re-financing.Then analyze the impact of targeted additional issuance on the performance of Kaileying.In the market performance section,the event research method is used to analyze the stock price of Kaile British after the incident,and analyze the announcement effect of the directional additions;Analysis method from debt repayment capacity,profitability,operating capacity,and growth capabilities,compared the financial status before and after the direction of the Kailei Group,and compared with the industry average,analyze whether the financial performance of Kailai Ying has been improved,and the comprehensive evaluation of the factor analysis method is used.Kailaiying’s financial performance.In the end,it was concluded that the market performance and financial performance of Kaile British in2020 were significantly significant.On the basis of the analysis of the previous article,a listed company that subsequently wants to make re-financing through the direction of increasing issuance will be provided with some suggestions.